<DOC>
	<DOCNO>NCT00715143</DOCNO>
	<brief_summary>The purpose study collect evaluate long-term safety effectiveness data Exactech® NOVATION ™ Ceramic Articulation Hip System ( `` NOVATION ™ Ceramic AHS '' ) . Ten ( 10 ) year follow-up data collect study . The first five ( 5 ) year subject follow-up involve clinical ( Harris Hip Score , adverse event ) , radiographic , self-assessment evaluation . The remain five ( 5 ) year subject follow-up accomplish outcome questionnaire complete subject evaluate survivorship status hip replacement .</brief_summary>
	<brief_title>Post Approval Study : NOVATION Ceramic Articulation Hip System</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria 1 . Patient undergoing primary hip surgery symptomatic Noninflammatory Degenerative Joint Disease ( NIDJD ) . Composite diagnosis NIDJD include osteo/ degenerative arthritis , traumatic arthritis , congenital hip dysplasia avascular necrosis . 2 . Patient 21 year age old time surgery . 3 . Patient skeletally mature ( tibial femoral epiphysis close ) . 4 . Patient willing able return followup specify study protocol ten ( 10 ) year postoperative followup period ; include 5 year inclinic visit follow 5 year mailin questionnaire followup . 5 . Patient female childbearing age , negative urine pregnancy test obtain immediately prior surgery . 6 . Patient meet Exclusion Criteria . 7 . Patient agree participate sign Informed Consent Form . Exclusion Criteria 1 . Patient le 21 year old time surgery . 2 . Patient skeletally immature . 3 . Patient present inflammatory degenerative joint disease . 4 . Patient evidence active infection , include asymptomatic urinary tract infection ( UTI ) treat antibiotic preoperatively . 5 . Patient female child bear age pregnant whose pregnancy status unknown . 6 . Patient neurological musculoskeletal disease may adversely affect gait weight bearing . 7 . Patient known presence active metastatic neoplastic disease ( active define within past 5 year . Does include basal cell carcinoma case subject diagnosis undergone radical excision lesion , pathological proof lesion clean clear peripheral deep border , location lesion near operative hip affect extremity ) . 8 . Patient poor bone quality ( e.g. , osteoporosis ) , investigator 's opinion , inadequate bone support implant ( ) . 9 . Patient presence previous prosthetic hip replacement device ( type , include THA , surface replacement arthroplasty , endoprosthesis , etc . ) operative hip joint . 10 . Patient know presence highly communicable disease disease may limit followup ( e.g. , immunocompromised condition , hepatitis , active tuberculosis , etc. ) . 11 . Patient prisoner . 12 . Patient obese obesity define Body Mass Index ( BMI ) great 35 . BMI = Weight ( lb . ) ÷ Height ( . ) 2 x 703 13 . Patient neuropathic joint . 14 . Patient known allergy implant material . 15 . Patient unwilling unable comply postoperative rehabilitation instruction weight bear limitation . 16 . Patient 's life expectancy &lt; 5 year due chronic disease cancer , congestive heart failure , etc . 17 . Patient unwilling unable ( e.g . case reduce mental capacity ) return followup specify study protocol ten ( 10 ) year postoperative followup period . 18 . Patient reduce mental capability ( permanent temporary ) would prevent follow presurgical postsurgical instruction . 19 . Patient otherwise meet study criterion refuse consent write participate study .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>hip</keyword>
	<keyword>replacement</keyword>
	<keyword>ceramic</keyword>
	<keyword>orthopaedic</keyword>
	<keyword>joint</keyword>
	<keyword>degenerative</keyword>
	<keyword>non-inflammatory</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>avascular necrosis</keyword>
	<keyword>congenital hip dysplasia</keyword>
	<keyword>traumatic arthritis</keyword>
</DOC>